Leu-Valorphin-Arg

• Description:

  Leu-Valorphin-Arg (LVV-hemorphin-6), an opioid active peptide, is an angiotensin converting enzyme (ACE) inhibitor. Leu-Valorphin-Arg can be used for hypertension research[1].

• UNSPSC:

  12352209

• Target:

  Angiotensin-converting Enzyme (ACE)

• Related Pathways:

  Metabolic Enzyme/Protease

• Field of Research:

  Cardiovascular Disease

• Smiles:

  O=C([C@H]1N(CCC1)C([C@@H](NC([C@H](C(C)C)NC([C@H](C(C)C)NC([C@@H](N)CC(C)C)=O)=O)=O)CC2=CC=C(C=C2)O)=O)N[C@H](C(N[C@@H]([C@H](O)C)C(N[C@@H](CCC(N)=O)C(N[C@H](C(O)=O)CCCNC(N)=N)=O)=O)=O)CC3=CNC4=CC=CC=C34

• Molecular Formula:

  C56H84N14O13

• Molecular Weight:

  1161.35

• References & Citations:

  [1]Lantz I, et al. Hemorphins derived from hemoglobin have an inhibitory action on angiotensin converting enzyme activity. FEBS Lett. 1991 Aug 5;287 (1-2) :39-41.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Peptides

• Clinical Information:

  No Development Reported

• CAS Number:

  [135861-77-7]